1 Background
2 Methods
2.1 Study design and inclusion criteria
2.2 Clinical assessment
2.3 Surgical management and postoperative care
2.4 Data collection
2.5 Newly modified nephrometry score (MNS)
2.6 Statistical analysis
3 Results
3.1 Demographic and perioperative data
51 patients | |
---|---|
Age (years) | 50.19 ± 13.25 (20–80) |
Sex: male/female | 29 (56.9%)/22 (43.1%) |
Medical disease (DM, HTN, IHD and/or stroke) | 25 (49%) |
CKD (ml/min/1.73 m2): > 90/60–89/30–59 | 17 (33.3%)/26 (51%)/8 (15.7%) |
Solitary kidney | 2 (3.9%) |
Side: right/left | 30 (58.8%)/21 (41.2%) |
Clinical T | |
1a | 11 (21.6%) |
1b | 25 (49%) |
2a | 13 (25.5%) |
2b | 2 (3.9%) |
Position: anterior/posterior/“X” | 15 (29.4%)/28 (54.9%)/8 (15.7%) |
Hilar position | 10 (19.6%) |
Renal Pelvic Score: extrarenal/intrarenal | 16 (31.4%)/35 (68.6%) |
Complexity: low/moderate/high | 11 (21.6%)/20 (39.2%)/20 (39.2%) |
Modified complexity: low/moderate/high | 15 (29.4%)/20 (39.2%)/16 (31.4%) |
Indications for PN | |
CKD | 3 (5.9%) |
Medical disease (HTN + DM) | 14 (27.4%) |
CKD + medical disease | 4 (7.8%) |
SRM/peripheral mass | 24 (47.0%) |
AML with bleeding | 3 (5.9%) |
Solitary | 1 (2%) |
Bilateral masses | 2 (3.9) |
BMI (kg/m2) | 29.8 ± 5.2 (21–42) |
ASA Score | 1 (1–2) |
Pre-Op eGFR (ml/min/1.73 m2) | 84.6 ± 24.5 (40–141) |
Pre-Op Hb (gm/dl) | 13.2 ± 1.7 (9.1–16.4) |
R.E.N.A.L. | 9 (4–12) |
MNS | 12 (6–22) |
Operative time (h) | 3 ± 0.7 (1.75–5) |
Ischemia type: warm ischemia/zero ischemia | 40 (78.4%)/11 (21.6%) |
WIT (min) | 15.1 ± 9.8 (0–40) |
PCS entry | 26 (51%) |
Blood transfusion | 9 (17.6%) |
Blood loss (ml) | 250 (50–1500) |
Conversion to radical nephrectomy | 4 (7.8%) |
Post-Op Hb (gm/dl) | 11.8 ± 1.8 (7.1–15.8) |
Hb loss (gm/dl) | 1 (0.10–5.3) |
Perioperative complicationsa | 17 (33.3%) |
Grade I | |
Fever | 7 (13.7%) |
Grade II | |
Blood transfusion | 9 (17.6%) |
Leakage (conservative) | 1 (2%) |
Perinephric collection and leak (conservative) | 1 (2%) |
Grade III | |
Leak (endoscopic stenting) | 3 (5.88%) |
Perinephric collection and leak (endoscopic stenting) | 1 (2%) |
AVF (Embolization) | 2 (3.9%) |
Ureteric injury | 2 (3.9%) |
Renal artery thrombosis/intimal injury | 2 (3.9%) |
Drain removal/length of hospital stay (days) | 5 (3–28)/5 (3–29) |
Pathological T | |
Benign | 11 (21.6%) |
1a/1b | 9 (17.6%)/17 (33.3%) |
2a/2b | 8 (15.7%)/5 (5.9%) |
3a | 1 (2%) |
Histologic type | |
Clear cell | 26 (51%) |
Papillary/chromophobe/esinophilic | 6 (11.8%)/7 (13.7%)/1 (2%) |
Benign lesions: (AML/oncocytoma) | 11 (21.56%) |
Fuhrman grade: I/II/III | 18 (35%)/21 (41.2%)/1 (2%) |
Positive surgical margin | 3 (5.9%) |
Post-Op eGFR 3 mo (ml/min/1.73 m2) | 77.7 ± 22.1 (21.8–130) |
3.2 Pathological data
3.3 Effect of complexity on outcome according to R.E.N.A.L. and MNS
Complexity level according to R.E.N.A.L. | p | |||
---|---|---|---|---|
Low (4–6) 11 patients | Moderate (7–9) 20 patients | High (10–12) 20 patients | ||
Age (years) | 48.1 ± 13.1 (20–59) | 50.3 ± 10.1 (34–65) | 51.1 ± 16.2 (20–80) | .861 |
BMI (kg/m2) | 32 ± 6.7 (22–42) | 28.5 ± 4.3 (22–36) | 29.6 ± 4.9 (21–39) | .117 |
ASA Score | 1 (1–2) | 1 (1–2) | 2 (1–2) | .441 |
Pre-Op eGFR (ml/min/1.73m2) | 86.1 ± 20.9 (55–141) | 76.9 ± 18.6 (43–126) | 91 ± 30 (40–140) | .183 |
Pre-Op Hb (gm/dl) | 14.1 ± 1.05 (13–15.9) | 13.2 ± 1.8 (10.5–16.4) | 12.6 ± 1.7 (9.1–15.5) | .064 |
Sex: male/female | 7 (63.6%)/4 (36.4%) | 13 (65%)/7 (35%) | 9/(45%)/11 (55%) | .388 |
Side: right/left | 8 (72.7%)/3 (27.3%) | 12 (60%)/8 (40%) | 10 (50%)/10 (50%) | .465 |
CKD (ml/min/1.73m2) | .104 | |||
> 90 | 4/11 (36.4%) | 3/20 (15%) | 10/20 (50%) | |
60–89 | 6/11 (54.5%) | 14/20 (70%) | 6/20 (30%) | |
30–59 | 1/11 (9.1%) | 3/20 (15%) | 4/20 (20%) | |
Clinical T | .095 | |||
T1 | 10/11 (90.9%) | 15/20 (75%) | 11/20 (55%) | |
T2 | 1/11 (9.1%) | 5/20 (25%) | 9/20 (45%) | |
OR time (h) | 2.6 ± 0.57 (1.7–3.5) | 3.1 ± 0.78 (2–5) | 3.03 ± 0.65 (2–4.5) | .174 |
WIT (min) | 14 (0–20) | 15 (0–30) | 19 (0–40) | .343 |
LOS (days) | 4 (3–9) | 5 (4–29) | 5 (4–11) | .109 |
Hb loss (gm/dl) | 1 (0.4–3.5) | 1 (0.2–3.7) | 1 (0.1–5.3) | .788 |
Blood loss (ml) | 150 (50–1500) | 300 (100–900) | 300 (50–1100) | .272 |
Ischemia type | .251 | |||
Warm ischemia | 7/11 (63.6%) | 18/20 (90%) | 15/20 (75%) | |
No ischemia | 4/11 (36.4%) | 2/20 (10%) | 5/20 (25%) | |
Hilar position | 0/11 | 3/20 (5.9%) | 7/20 (13.7%) | .053 |
RPS | ||||
Intrarenal/extrarenal | 7 (63.6%)/4 (36.4%) | 14 (70%)/6 (30%) | 14 (70%)/6 (30%) | .922 |
PCS entry | 5/11 (45.5%) | 8/20 (40%) | 13/20 (65%) | .263 |
Post-Op Hb (gm/dl) | 12.6 ± 1.5 (10 - 14.3) | 11.9 ± 1.6 (9 - 15.8) | 11.3 ± 2 (7.1–15) | .148 |
Total complications | 2/11 (18.2%) | 9/20 (52.9%) | 6/20 (30%) | .292 |
Secondary intervention | 2/11 (18.2%) | 7/20 (35%) | 1/20 (5%) | .039* |
VC | 1/11 (9.1%) | 2/20 (10%) | 1/20 (5%) | 1 |
Ureteric injury | 0/11 | 2/20 (10%) | 0/20 | .341 |
Blood transfusion | 2/11 (18.2%) | 3/20 (15%) | 4/20 (20%) | 1 |
Leakage | 0/11 | 5/20 (25%) | 1/20 (5%) | .124 |
Drain removal (d) | 4 (3–8) | 4.5 (3–28) | 5 (4–7) | .243 |
Conversion to RN | 1/11 (9.1%) | 1/20 (5%) | 2/20 (10%) | 1 |
RF impairment | 1/11 (9.1%) | 2/20 (10%) | 3/20 (11.8%) | 1 |
Positive margin | 0/11 | 1/20 (5%) | 2/20 (10%) | .789 |
Post-Op eGFR 3mo (ml/min/1.73m2) | 78.6 ± 17.5 (60–114.3) | 74.8 ± 19.3 (32–117) | 80.1 ± 27 (21.8–130) | .750 |
Complexity according to MNS | p | |||
---|---|---|---|---|
Low (5–9) 15 patient | Moderate (10–14) 20 patient | High (15–23) 16 patient | ||
Age (years) | 49.3 ± 12.3 (20–63) | 51.9 ± 13.7 (30–80) | 48.8 ± 13.9 (20–65) | .941 |
BMI (kg/m2) | 31.4 ± 6.2 (22–42) | 27.3 ± 4.1 (21–36) | 31.4 ± 4.5 (25–39) | .022* |
ASA Score | 1 (1–2) | 1 (1–2) | 2 (1–2) | .404 |
Pre-Op eGFR (ml/min/1.73m2) | 84.9 ± 18.7 (55–141) | 81.7 ± 25.3 (43–130) | 87.3 ± 29.1 (40–140) | .788 |
Pre-Op Hb (gm/dl) | 14 ± 1.3 (11.4–16.4) | 12.7 ± 1.9 (9.1–15.8) | 13 ± 1.5 (10.1–15.6) | .091 |
Sex: male/female | 8 (53.3%)/7 (46.7%) | 11 (55%)/9 (45%) | 10 (56.9%)/6 (37.5%) | .856 |
Side: right/left | 11 (73.3%)/4 (26.7%) | 8 (40%)/12 (60%) | 11 (68.8%)/5 (31.3%) | .087 |
CKD (ml/min/1.73m2) | .583 | |||
> 90 | 5/15 (33.3%) | 5/20 (25%) | 7/16 (43.8%) | |
60–89 | 9/15 (60%) | 11/20 (55%) | 6/16 (37.5%) | |
30–59 | 1/15 (6.7%) | 4/20 (20%) | 3/16 (18.8%) | |
Clinical T | .216 | |||
T1 | 13/15 (86.7%) | 14/20 (70%) | 9/16 (56.2%) | |
T2 | 2/15 (13.3%) | 6/20 (30%) | 7/16 (43.8%) | |
OR time (h) | 2.7 ± 0.67 (1.7–4.25) | 3 ± 0.79 (2–5) | 3.1 ± 0.57 (2.25–4) | .153 |
WIT (min) | 14 (0–20) | 18.5 (0–40) | 16.5 (0–27) | .070 |
LOS (day) | 4 (3–9) | 5 (4–29) | 5 (4–14) | .077 |
Hb loss (gm/dl) | 1 (0.2–3.5) | 1 (0.10–3.7) | 1 (0.1–5.3) | .937 |
Blood loss (ml) | 150 (50–1500) | 275 (50–900) | 475 (50–1100) | .081 |
Ischemia type | .317 | |||
Warm ischemia | 11/15 (73.3%) | 18/20 (90%) | 11/16 (68.8%) | |
No ischemia | 4/15 (26.7%) | 2/20 (10%) | 5/16 (31.2%) | |
Hilar position | 0/10 | 0/10 | 10/10 (100%) | <.001* |
RPS | .049* | |||
Intrarenal/extrarenal | 7 (46.7%)/8 (53.3%) | 14 (70%)/6 (30%) | 14 (87.5%)/2 (12.5%) | |
PCS entry | 5/15 (33.3%) | 11/20 (55%) | 10/16 (62.5%) | .241 |
Post-Op Hb (gm/dl) | 12.7 ± 1.5 (10–15.8) | 11.4 ± 1.8 (7.1–14.5) | 11.5 ± 1.7 (8.6–15) | .074 |
Total complications | 2/15 (13.3%) | 6/20 (30%) | 9/16 (56.3%) | .037* |
Secondary intervention | 2/15 (13.3%) | 5/20 (25%) | 3/16 (18.8%) | .757 |
VC | 1/15 (6.7%) | 2/20 (10%) | 1/16 (6.3%) | 1 |
Ureteric injury | 0/15 | 1/20 (5%) | 1/16 (6.3%) | 1 |
Blood Transfusion | 2/15 (13.3%) | 2/20 (10%) | 5/16 (31.3%) | .269 |
Leakage | 0/15 | 4/20 (20%) | 2/16 (12.5%) | .255 |
Drain removal (d) | 4 (3–8) | 4.5 (4–28) | 5 (3–14) | .200 |
Conversion to RN | 1/15 (6.7%) | 1/20 (5%) | 2/16 (12.5%) | .818 |
RF impairment | 1/15 (6.7%) | 2/20 (10%) | 3/16 (18.8%) | .647 |
Positive margin | 0/15 | 0/20 | 3/16 (18.8%) | .049* |
Post-Op eGFR 3mo (ml/min/1.73m2) | 79.6 ± 15.4 (60–114) | 78.3 ± 23.1 (27–117) | 75.3 ± 26.7 (21.8–130) | .856 |
3.4 Predicting factors for postoperative complications
Patient without complications 34 patient | Patient with complications 17 patient | p | |
---|---|---|---|
Age (years) | 50.4 ± 14.76 (20–80) | 49.6 ± 9.9 (30–65) | .815 |
BMI (kg/m2) | 29.1 ± 5 (21–40) | 31.3 ± 5.6 (25–42) | .151 |
ASA Score | 1 (1–2) | 2 (1–2) | .327 |
Pre-Op eGFR (ml/min/1.73m2) | 86.6 ± 26.2 (43–141) | 80 ± 20.9 (40–130) | .372 |
Pre-Op Hb (gm/dl) | 13.3 ± 1.8 (9.1–16.4) | 12.9 ± 1.5 (10.8–15.8) | .399 |
Sex | .842 | ||
Male | 19/29 (65.5%) | 10/29 (34.5%) | |
Female | 15/22 (68.2%) | 7/22 (31.8%) | |
Side | .07 | ||
Right | 23/30 (76.7%) | 7/30 (23.3%) | |
Left | 11/21 (52.4%) | 10/21 (47.6%) | |
Solitary kidney | 1/2 (50%) | 1/2 (50%) | 1 |
CKD (ml/min/1.73m2) | .381 | ||
> 90 | 13/17 (76.5%) | 4/17 (23.5%) | |
60–89 | 15/26 (57.7%) | 11/26 (42.3%) | |
30–59 | 6/8 (75%) | 2/8 (25%) | |
cT | .192 | ||
T1 | 26/36 (72.2%) | 10/36 (27.8%) | |
T2 | 8/15 (53.3%) | 7/15 (46.7%) | |
RPS | .393 | ||
Intrarenal | 22/35 (62.9%) | 13/35 (37.1%) | |
Extrarenal | 12/16 (75%) | 4/16 (25%) | |
R | .122 | ||
1 | 10/11 (90.9%) | 1/11 (9.1%) | |
2 | 17/27 (63%) | 10/27 (37%) | |
3 | 7/13 (53.8%) | 6/13 (46.2%) | |
E | .421 | ||
1 | 10/15 (66.7%) | 5/15 (33.3%) | |
2 | 19/26 (73.1%) | 7/26 (26.9%) | |
3 | 5/10 (50%) | 5/10 (50%) | |
N | .755 | ||
1 | 10/15 (66.7%) | 5/15 (33.3%) | |
2 | 9/12 (75%) | 3/12 (25%) | |
3 | 15/24 (62.5%) | 9/24 (37.5%) | |
L | .387 | ||
1 | 7/8 (87.5%) | 1/8 (12.5%) | |
2 | 11/17 (64.7%) | 6/17 (35.3%) | |
3 | 16/26 (61.5%) | 10/26 (38.5%) | |
Hilar position | 2/10 (20%) | 8/10 (80%) | .001* |
Complexity | .292 | ||
Low | 9/11 (81.8%) | 2/11 (18.2%) | |
Moderate | 11/20 (55%) | 9/20 (45%) | |
High | 14/20 (70%) | 6/20 (30%) | |
Modified complexity | .037* | ||
Low | 13/15 (86.7%) | 2/15 (13.3%) | |
Moderate | 14/20 (70%) | 6/20 (30%) | |
High | 7/16 (43.8%) | 9/16 (56.2%) | |
R.E.N.A.L. | 8 (4–12) | 9 (6–11) | .151 |
MNS | 11 (6–19) | 15 (7–22) | .014* |